Brentuximab vedotin — a new standard for cutaneous T-cell lymphoma
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.94
Published Online: 2017-06-20
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Killock, David
Text and Data Mining valid from 2017-06-20
Article History
First Online: 20 June 2017